MX2018006381A - Composiciones de aceite de cannabis y metodos para preparacion de las mismas. - Google Patents
Composiciones de aceite de cannabis y metodos para preparacion de las mismas.Info
- Publication number
- MX2018006381A MX2018006381A MX2018006381A MX2018006381A MX2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A MX 2018006381 A MX2018006381 A MX 2018006381A
- Authority
- MX
- Mexico
- Prior art keywords
- cannabis oil
- oil compositions
- methods
- produce
- cannabis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención proporciona composiciones de aceite de cannabis, que incluyen composiciones de aceite de cannabis que contienen vitamina E, y métodos para preparar las composiciones de aceite de cannabis. En algunas realizaciones, la invención proporciona un método para preparar una composición de aceite de cannabis que comprende eluir cannabinoides del material vegetal de cannabis con un disolvente para producir un eluato; filtrar el eluato con un filtro para producir un filtrado; evaporar el disolvente del filtrado con un destilador para producir un destilado; y purgar el destilado en condiciones suficientes para eliminar el disolvente residual. En algunas realizaciones, el método incluye además mezclar una cantidad de vitamina E con el extracto. También se describen composiciones de aceite de cannabis mezclado que contienen mezclas de preparaciones de aceite de cannabis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562259549P | 2015-11-24 | 2015-11-24 | |
PCT/US2016/063662 WO2017091764A1 (en) | 2015-11-24 | 2016-11-23 | Cannabis oil compositions and methods for preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018006381A true MX2018006381A (es) | 2019-02-14 |
Family
ID=58763660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018006381A MX2018006381A (es) | 2015-11-24 | 2016-11-23 | Composiciones de aceite de cannabis y metodos para preparacion de las mismas. |
Country Status (8)
Country | Link |
---|---|
US (3) | US10806707B2 (es) |
EP (1) | EP3380096A4 (es) |
AU (1) | AU2016359160A1 (es) |
CA (1) | CA3006182A1 (es) |
CO (1) | CO2018006452A2 (es) |
IL (2) | IL299047A (es) |
MX (1) | MX2018006381A (es) |
WO (1) | WO2017091764A1 (es) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10188086B2 (en) * | 2016-08-21 | 2019-01-29 | Daniel Michael Leo | Insect production systems and methods |
AU2016211314A1 (en) * | 2015-01-31 | 2017-08-17 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
US10035081B2 (en) * | 2016-04-14 | 2018-07-31 | Capna Intellectual, Inc. | Methods to reduce chlorophyll co-extraction through extraction of select moieties essential oils and aromatic isolates |
WO2018023164A1 (en) * | 2016-08-03 | 2018-02-08 | Zelda Therapeutics Operations Pty Ltd | Cannabis composition |
US10264768B2 (en) * | 2016-08-21 | 2019-04-23 | Daniel Michael Leo | Insect production systems and methods |
US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
US10716819B2 (en) * | 2017-02-22 | 2020-07-21 | Yabuwi, Inc. | Food grade cannabis extracts and methods for their preparation |
CA3103178A1 (en) | 2017-06-27 | 2019-01-03 | Enviro BioMedical Laboratories Inc. | Blended cannabis compounds and methods of making the same |
IL272709B2 (en) * | 2017-09-08 | 2024-09-01 | Scicann Therapeutics Inc | The compounds containing cannabinoid and spilantol |
IT201700106078A1 (it) * | 2017-09-22 | 2019-03-22 | Meschiari Guido | Composizione farmaceutica a base di cannabinoidi. |
CA3089994A1 (en) | 2018-01-31 | 2019-08-08 | Canopy Holdings, LLC | Hemp powder |
WO2019165387A1 (en) * | 2018-02-23 | 2019-08-29 | Spirtos Nicola Michael | Cannabis based therapeutic and method of use |
US20230110830A1 (en) * | 2018-04-09 | 2023-04-13 | Ellevet Sciences | Hemp extract for treatment of pain in animals |
CN110554100B (zh) * | 2018-06-01 | 2021-06-22 | 江苏康缘药业股份有限公司 | 一种杏贝止咳颗粒指纹图谱建立及其成分检测方法 |
WO2019237156A1 (en) * | 2018-06-15 | 2019-12-19 | CannPal Animal Therapeutics Limited | Cannabinoid composition and methods of treatment using the same |
WO2020021544A1 (en) * | 2018-07-25 | 2020-01-30 | Bol Pharma Ltd. | Cannabidiol and methylthio-butyl-isothiocyanate for treating inflammatory diseases |
CN108815280A (zh) * | 2018-08-09 | 2018-11-16 | 集美大学 | 一种用于治疗石斑鱼变形假单胞菌病的中药组合物及其制备方法和应用 |
CN108635446A (zh) * | 2018-08-09 | 2018-10-12 | 集美大学 | 一种利用中西药联用治疗石斑鱼变形假单胞菌病的组合物及其制备方法和应用 |
WO2020037133A1 (en) * | 2018-08-17 | 2020-02-20 | Shepard Kirsten K | Cannabidiol composition and methods thereof |
US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
WO2020097726A1 (en) * | 2018-11-13 | 2020-05-22 | Hexo Operations Inc. | Method of manufacturing vape oil including a cannabinoid for use in a vape device |
CN109431830B (zh) * | 2018-12-18 | 2021-07-27 | 陈东升 | 一种抗氧化的天然组合物、食品、化妆品、保健品和药物 |
AU2019412825A1 (en) * | 2018-12-27 | 2021-08-12 | Buzzelet Development And Technologies Ltd. | Herbal preparation-enriched cannabinoid composition and method of treatment |
SG11202110779SA (en) * | 2019-05-06 | 2021-10-28 | Univ British Columbia | Antibiotic cannabinoid-terpene formulations |
WO2020255133A1 (en) * | 2019-06-18 | 2020-12-24 | The Cures Ltd. | Novel therapeutic preparations comprising scutellaria barbata |
EP4025198A4 (en) * | 2019-09-06 | 2023-09-13 | Quicksilver Scientific, Inc. | MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES |
WO2021050429A1 (en) * | 2019-09-10 | 2021-03-18 | Pureform Global, Inc. | Topical composition for treatment of pain |
US11021675B2 (en) * | 2019-09-13 | 2021-06-01 | Thar Process, Inc. | Process for producing refined oils from botanical plant matter using a supercritical fluid |
US11826673B2 (en) * | 2019-10-25 | 2023-11-28 | Chimera Technology LLC | Solvent-less extraction of cannabinoid acids |
US10946306B1 (en) * | 2019-11-27 | 2021-03-16 | World Class Extractions Inc. | Solvent-based extraction methods |
CA3164293A1 (en) * | 2020-01-10 | 2021-07-15 | Real Isolates, Llc | Methods for obtaining compounds from a plant or fungus material, respective compositions, and uses thereof |
CN111171127B (zh) * | 2020-02-26 | 2021-07-30 | 浙江省农业科学院 | 紫云英lhy基因及其应用 |
EP4120848A4 (en) * | 2020-03-17 | 2024-07-24 | Epidarus Therapeutics Llc | COMPOSITIONS FOR INHIBITING THE DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF |
WO2021191888A1 (en) * | 2020-03-26 | 2021-09-30 | I.P. Israel Patents Ltd. | Cannabis sativa (hemp and cannabis) products for viral disease prevention and management |
US11583574B2 (en) | 2020-04-02 | 2023-02-21 | Mitchell Lynn Tate | Treatement of pathogen infections formulations and methods for use |
US20230348645A1 (en) * | 2020-04-29 | 2023-11-02 | Ligar Limited Partnership | Imprinted polymers and methods for their use |
EP4157259A1 (en) * | 2020-05-24 | 2023-04-05 | Asana Bio Group Ltd. | Compositions of cannabinoids and methods of using same |
EP4185131A1 (en) * | 2020-07-21 | 2023-05-31 | AI Pharmaceuticals Jamaica Limited | Compositions and methods for treatment of cancers |
US20240050451A1 (en) * | 2020-09-25 | 2024-02-15 | Mdm Enterprise Solutions Inc. | Precision cannabinoid therapy formulations and methods of use |
WO2022091050A1 (en) * | 2020-10-31 | 2022-05-05 | Ai Pharmaceuticals Jamaica Limited | Compositions for treatment of interstitial cystitis and other bladder disease |
US20220226241A1 (en) * | 2021-01-20 | 2022-07-21 | Therabody, Inc. | Stable organic cannabinoid oil blend formulations |
WO2022165439A1 (en) * | 2021-02-01 | 2022-08-04 | Aion Therapeutic Inc. | Methods for treatment of human cancers using cannabis compositions |
CN113070484A (zh) * | 2021-03-10 | 2021-07-06 | 海南华创槟榔研究院 | 一种尺寸可控球形纳米银粒子、制备方法及应用 |
US11633425B2 (en) | 2021-05-13 | 2023-04-25 | Ahava—Dead Sea Laboratories Ltd. | Anti-glycation compositions |
AU2022313978A1 (en) * | 2021-07-23 | 2024-02-08 | Ojai Energetics Pbc | Methods and compositions for microencapsulated compounds |
CN113577076B (zh) * | 2021-08-11 | 2023-08-18 | 湖南农业大学 | 一种钩吻素子在制备治疗急性肺损伤药物中的应用 |
AU2021107253A4 (en) * | 2021-08-24 | 2021-12-09 | Cymra Life Sciences Limited | A composition and uses thereof |
IT202100028997A1 (it) * | 2021-11-16 | 2023-05-16 | C I A M S R L | Composizioni utili per ridurre il declino cognitivo in animali da compagnia |
US11911427B2 (en) | 2022-03-12 | 2024-02-27 | Wilhelm Rumpf | Extraction and infusion of active components from plant materials |
BE1030549B1 (fr) * | 2022-05-23 | 2023-12-18 | Laboratoire Puressentiel S A | Complément alimentaire |
CN114766679B (zh) * | 2022-06-22 | 2022-08-30 | 北京中科生仪科技有限公司 | 一种美白、抗氧化组合物及其制剂、制备工艺与应用 |
GB202210304D0 (en) * | 2022-07-13 | 2022-08-24 | Hytn Group Ltd | Composition comprising cannabidiol |
CN115337239B (zh) * | 2022-08-31 | 2023-08-18 | 广州研智化妆品有限公司 | 一种具有舒缓及修复功效的精华油及其制备方法 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
GB9726916D0 (en) | 1997-12-19 | 1998-02-18 | Danbiosyst Uk | Nasal formulation |
US6082370A (en) | 1998-02-09 | 2000-07-04 | Rousseau Research, Inc. | Cigarette with dry powered Vitamin E |
US6797507B2 (en) | 2000-03-03 | 2004-09-28 | George E. Hahn | Methods of using worm castings for fungal control |
GB2377218A (en) | 2001-05-04 | 2003-01-08 | Gw Pharmaceuticals Ltd | Process and apparatus for extraction of active substances and enriched extracts from natural products |
US20030134018A1 (en) | 2001-12-31 | 2003-07-17 | Cargill, Inc. | Process for oil extraction |
GB2384184B (en) | 2002-01-10 | 2005-01-12 | Aea Technology Plc | Cannabis aerosol |
WO2003063847A1 (en) | 2002-02-01 | 2003-08-07 | Gw Pharma Limited | Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions |
US7344736B2 (en) | 2002-08-14 | 2008-03-18 | Gw Pharma Limited | Extraction of pharmaceutically active components from plant materials |
GB2418612A (en) | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
GB2439393B (en) | 2006-06-23 | 2011-05-11 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
GB2448535A (en) | 2007-04-19 | 2008-10-22 | Gw Pharma Ltd | New use for cannabinoid-containing plant extracts |
US20090130220A1 (en) | 2007-11-20 | 2009-05-21 | Johnson Pamela A | Cosmetic composition having pomace olive oil |
GB2471987B (en) | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
GB2475183B (en) | 2008-06-04 | 2011-11-23 | Gw Pharma Ltd | Cannabinoids in combination with non-cannabinoid chemotherapeutic agent that are selective estrogen receptor modulators |
EP2201942A1 (de) | 2008-12-23 | 2010-06-30 | Intendis GmbH | Zusammensetzung mit Hanföl für die Behandlung topischer Erkrankungen |
GB2471523A (en) | 2009-07-03 | 2011-01-05 | Gw Pharma Ltd | Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy |
GB2478595B (en) | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Gw伐瑪有限公司 | 使用植物大麻素次大麻二酚(cbdv)來治療癲癇之用途 |
US8445034B1 (en) | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
WO2012071389A2 (en) | 2010-11-22 | 2012-05-31 | Johnson Matthey Public Limited Company | Stable cannabinoid compositions and methods for making and storing them |
GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
ITMI20111806A1 (it) | 2011-10-05 | 2013-04-06 | Freia Farmaceutici S R L | Composizione per il trattamento delle lesioni cutanee |
GB201117956D0 (en) * | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
GB201119198D0 (en) | 2011-11-07 | 2011-12-21 | Jack Amanda | Removal of surgical casts |
DK2844243T3 (da) | 2012-05-03 | 2020-02-03 | Echo Pharmaceuticals Bv | Fremgangsmåde til fremstilling af et cannabisplante-isolat omfattende delta-9-tetrahydrocannabinol |
US9700310B2 (en) | 2013-08-23 | 2017-07-11 | Ethicon Llc | Firing member retraction devices for powered surgical instruments |
CN103005427B (zh) | 2012-11-23 | 2013-11-27 | 浙江华立生命科技有限公司 | 改进的含火麻仁油的保健品组合物及其制备方法 |
US10792318B2 (en) | 2013-03-14 | 2020-10-06 | Sc Laboratories, Inc. | Bioactive concentrates and uses thereof |
US9199960B2 (en) | 2013-05-02 | 2015-12-01 | Frederick R. Ferri | Method and apparatus for processing herbaceous plant materials including the cannabis plant |
US20150057342A1 (en) * | 2013-08-21 | 2015-02-26 | Cannabics Pharmaceuticals Inc | Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
US10106760B2 (en) | 2013-10-14 | 2018-10-23 | Jayson Emo | Organic based extraction system |
US9333229B2 (en) | 2013-10-16 | 2016-05-10 | William Bjorncrantz | Winterized crude cannabis extracts and methods of preparation and use |
CN105792687A (zh) | 2013-11-15 | 2016-07-20 | Jj206有限责任公司 | 用于汽化装置以及产品使用控制和文档化的系统和方法 |
US8906429B1 (en) | 2013-12-11 | 2014-12-09 | Jeffrey A. Kolsky | Medical cannabis lozenges and compositions thereof |
US9597279B2 (en) | 2014-02-28 | 2017-03-21 | HDDC Holdings, LLC | Anti-aging dermal composition comprising herbal extracts |
US9186386B2 (en) * | 2014-04-17 | 2015-11-17 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
CN104304815A (zh) | 2014-11-11 | 2015-01-28 | 广西壮族自治区水牛研究所 | 一种能提高水牛抗氧化机能的饲粮 |
-
2016
- 2016-11-23 IL IL299047A patent/IL299047A/en unknown
- 2016-11-23 AU AU2016359160A patent/AU2016359160A1/en not_active Abandoned
- 2016-11-23 WO PCT/US2016/063662 patent/WO2017091764A1/en active Application Filing
- 2016-11-23 CA CA3006182A patent/CA3006182A1/en active Pending
- 2016-11-23 US US15/778,192 patent/US10806707B2/en active Active
- 2016-11-23 EP EP16869303.4A patent/EP3380096A4/en active Pending
- 2016-11-23 MX MX2018006381A patent/MX2018006381A/es unknown
-
2018
- 2018-05-23 IL IL259571A patent/IL259571A/en unknown
- 2018-06-22 CO CONC2018/0006452A patent/CO2018006452A2/es unknown
-
2020
- 2020-10-16 US US17/072,626 patent/US20210275465A1/en not_active Abandoned
-
2023
- 2023-10-17 US US18/488,736 patent/US20240285549A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US10806707B2 (en) | 2020-10-20 |
AU2016359160A1 (en) | 2018-06-14 |
CA3006182A1 (en) | 2017-06-01 |
WO2017091764A1 (en) | 2017-06-01 |
IL299047A (en) | 2023-02-01 |
US20180344661A1 (en) | 2018-12-06 |
US20210275465A1 (en) | 2021-09-09 |
EP3380096A4 (en) | 2019-10-23 |
IL259571A (en) | 2018-07-31 |
CO2018006452A2 (es) | 2018-08-31 |
US20240285549A1 (en) | 2024-08-29 |
EP3380096A1 (en) | 2018-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018006381A (es) | Composiciones de aceite de cannabis y metodos para preparacion de las mismas. | |
MX2017009846A (es) | Metodos para la preparacion de extractos y composiciones de aceite de cannabis. | |
MX2020001443A (es) | Sistema y métodos de extracción fitoquímica para extraer fitoquímicos de plantas incluidas las plantas de la familia cannabaceae sensu stricto. | |
IN2014DN09507A (es) | ||
MX2017014195A (es) | Hidrogenacion de aceite de cannabis. | |
MX2020013853A (es) | Compuestos innovadores. | |
NZ753945A (en) | Cold brew coffee beverage and method of making the same | |
WO2020117688A3 (en) | Process for purifying tetrahydrocannabinol using a chromatographic stationary phase | |
MX2017015083A (es) | Composiciones cosmeticas que comprenden e/z-bencilideno-5,6-dimeto xi-3,3-dimetilindan-1-ona. | |
PH12017500876A1 (en) | Modification of plant lipids containing pufas | |
MX2016008266A (es) | Sustancias químicas aromáticas novedosas. | |
GB201102691D0 (en) | Method for handling zeotropic refrigerant mixtures | |
MX2020007960A (es) | Metodos para purificar cannabinoides usando cromatografia liquido-liquido. | |
AU2015217822A8 (en) | Method for producing vitamin E-enriched, especially tocotrienol-enriched, compositions from natural oils | |
MX2017006545A (es) | Proceso para la preparacion de 1-(2,6,6-trimetilciclohexil)-alcan- 3-oles. | |
MX2017014092A (es) | Metodo para obtener una biomasa de una microalga de la especie tetraselmis chuii enriquecida en superoxido dismutasa (sod). | |
WO2019088630A3 (ko) | 황-탄소 복합체 및 그의 제조방법 | |
GB201314565D0 (en) | Method and apparatus for improved resolution chromatography | |
GB2540539A (en) | A liquid containing 99% pure CBD for use in vapourizers, distinct from smoking or combustion devices | |
KR20160072407A (ko) | 도토리 유효성분의 분리 및 항산화력 | |
EP3238732A4 (en) | Anti-gout composition containing mixture extract of chrysanthemum indicum and cinnamomum cassia as active ingredient | |
PH12017500291A1 (en) | Purification of polyphenols | |
MX2018008812A (es) | Composicion farmaceutica liquida compuesta que comprende polvo seco estabilizante de farmaco en bruto. | |
CN105581932A (zh) | 一种百里香香水及其制备方法 | |
EA202091455A1 (ru) | Стабилизированный фармацевтический состав, содержащий эверолимус |